| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.074 | 0.2 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.031 | 0.5 |